Production (Stage)
CG Oncology, Inc.
CGON
$25.46
-$0.40-1.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -105.56M | -88.04M | -72.80M | -62.54M | -53.77M |
| Total Depreciation and Amortization | 52.00K | 32.00K | 36.00K | 19.00K | 16.00K |
| Total Amortization of Deferred Charges | -- | -- | -9.00K | -5.50K | -2.00K |
| Total Other Non-Cash Items | 11.76M | 6.39M | -522.00K | -1.17M | -517.00K |
| Change in Net Operating Assets | 11.77M | 2.91M | 597.00K | -2.48M | -5.15M |
| Cash from Operations | -81.98M | -78.71M | -72.70M | -66.16M | -59.43M |
| Capital Expenditure | -238.00K | -234.00K | -25.00K | -29.00K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -179.85M | -300.53M | -296.11M | -315.78M | -267.23M |
| Cash from Investing | -180.09M | -300.76M | -296.14M | -315.81M | -267.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -365.00K | -372.00K | -8.48M | -16.60M |
| Issuance of Common Stock | 226.34M | 632.07M | 408.92M | 406.87M | 406.91M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 410.00K | 410.00K | 410.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -269.00K | -3.42M | -6.99M | -6.99M | -6.95M |
| Cash from Financing | 226.07M | 628.28M | 401.97M | 391.81M | 383.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.00M | 248.80M | 33.14M | 9.83M | 57.09M |